1.90 - 2.15
0.48 - 2.54
9.88M / 3.06M (Avg.)
-0.59 | -3.40
View analysts' price targets and recommendations, and compare them with competitors.
No Data
No price target data available for this metric.
Hold
Positive consensus among analysts.
Analyze analyst forecasts for the company and compare them with competitors.
1.30B
The estimated revenue has increased from the previous period.
-509.05M
The estimated EBITDA has decreased from the previous period.
-0.18
The estimated EPS has increased from the previous period.
-132.07M
The estimated net income has increased from the previous period.
-626.86M
The estimated EBIT has decreased from the previous period.
430.67M
The estimated SG&A expenses have increased from the previous period.
Analyze DCF forecasts for the company and compare them with competitors.
2.35B
Revenue has increased from the previous period.
19.82%
Revenue growth rate is unchanged from the previous period.
-918.11M
EBITDA has decreased from the previous period.
-39.14%
EBITDA margin is unchanged from the previous period.
-1.13B
EBIT has decreased from the previous period.
-48.20%
EBIT margin is unchanged from the previous period.
309.83M
Depreciation has increased from the previous period.
1.68B
Total cash has increased from the previous period.
71.52%
Cash percentage is unchanged from the previous period.
346.60M
Receivables have increased from the previous period.
14.78%
Receivables percentage is unchanged from the previous period.
946.31M
Inventories have increased from the previous period.
40.34%
Inventory percentage is unchanged from the previous period.
269.01M
Accounts payable has increased from the previous period.
11.47%
Payables percentage is unchanged from the previous period.
-208.47M
Capital expenditure has increased from the previous period.
-8.89%
CapEx percentage is unchanged from the previous period.
14.21%
WACC is unchanged from the previous period.
14.92%
Cost of equity is unchanged from the previous period.
12.72%
Cost of debt is unchanged from the previous period.
2.19
Beta is unchanged from the previous period.
742.65M
Diluted shares outstanding is unchanged from the previous period.
558.58M
Total debt is unchanged from the previous period.
1.30B
Total equity is unchanged from the previous period.
1.86B
Total capital is unchanged from the previous period.
30.06%
Debt weighting is unchanged from the previous period.
69.94%
Equity weighting is unchanged from the previous period.
-1.12B
EBIAT has decreased from the previous period.
-1.18B
UFCF has decreased from the previous period.
2.00%
Long-term growth rate is unchanged from the previous period.
-11.86B
Terminal value is unchanged from the previous period.
-9.55B
Enterprise value is unchanged from the previous period.
229.28M
Net debt is unchanged from the previous period.
-9.78B
Equity value is unchanged from the previous period.
-13.17
Equity value per share is unchanged from the previous period.
